Bibliographic Details
Title: |
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment |
Authors: |
Ao, Wei, Kim, Hong Im, Tommarello, Domenic, Conrads, Kelly A., Hood, Brian L., Litzi, Tracy, Abulez, Tamara, Teng, Pang-Ning, Dalgard, Clifton L., Zhang, Xijun, Wilkerson, Matthew D., Darcy, Kathleen M., Tarney, Christopher M., Phippen, Neil T., Bakkenist, Christopher J., Maxwell, G. Larry, Conrads, Thomas P., Risinger, John I., Bateman, Nicholas W. |
Source: |
In Gynecologic Oncology October 2023 177:60-71 |
Database: |
ScienceDirect |